- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Tuberculosis (TB)
Source: Health Policy Watch 21st August 2019 The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, … Continue reading
Source: Health Policy Watch 19th August, 2019 NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant … Continue reading
Source: Third World Network 13th August, 2019 TWN Info Service on Health Issues (May19/03) 9 May 2019 Third World Network Shri J. P. Nadda Hon’ble Minister of Health and Family Welfare Room No. 348, ‘A’ Wing Nirman Bhavan, New Delhi-110011 … Continue reading
Source: Lawyers collective 13th August, 2019 Survivors of drug resistant tuberculosis, health organisations and the TB community in India and across the globe have appealed to the Prime Minister of India to issue a government use compulsory license for two … Continue reading
Civil Society letter to minimize injectables and scale up new drugs in drug-resistant tuberculosis (DR-TB) regimen
13th Aug, 2019 To, Dr. K.S. Sachdeva, Addl DDG, Central TB Division, MoHFW, NirmanBhawan, New Delhi – 110011 Mr. Sanjeeva Kumar, Additional Secy (Health), MoHFW, 254-A, NirmanBhawan, New Delhi – 110011 Prof. Vinod K. Paul, Member, NITI Aayog, Government … Continue reading
Source: Health Policy Watch 18th June, 2019 Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the … Continue reading